Companies / SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc.
Nasdaq: SGPSPGCIK 1778922IRVINE, CA
Financials
Ownership
33.4M shares outstanding · as of Jul 29, 2026
Ownership
| Insiders | 50.56% | 16,912,218 |
| 10%+ / strategic | 196.63% | 65,769,539 |
| Institutions | 6.17% | 2,062,582 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 32
View all →| Insider | % of shares | Shares |
|---|---|---|
Baskett Forest10% owner | 22.10% | 7,392,301 |
Behbahani AliDirector · 10% owner | 22.10% | 7,392,301 |
Chang Carmen10% owner | 22.10% | 7,392,301 |
Florence Anthony A. Jr.10% owner | 22.10% | 7,392,301 |
Makhzoumi Mohamad10% owner | 22.10% | 7,392,301 |
Sandell Scott D10% owner | 22.10% | 7,392,301 |
Walker Paul Edward10% owner | 22.10% | 7,392,301 |
Mathers Edward T10% owner | 18.04% | 6,035,038 |
New Enterprise Associates 17, L.P.10% owner | 18.04% | 6,035,038 |
Yang Rick10% owner | 18.04% | 6,035,038 |
Institutional holders 10
View all →| Holder | Value | % of shares |
|---|---|---|
| $207.83M | 23.98% | |
| $15.84M | 2.13% | |
| $14.25M | 1.64% | |
| $12.15M | 1.40% | |
| $3.28M | 0.38% | |
| $2.62M | 0.35% | |
| $1.23M | 0.14% | |
| $760.4K | 0.09% | |
| $244.0K | 0.03% | |
| $2.0K | <0.01% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common Stock | $207.83M | +8.0M | 8,021,117 23.98% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common Stock | $15.84M | +712K | 711,712 2.13% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | New | Common Stock | $14.25M | +550K | 550,000 1.64% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $12.15M | +469K | 468,794 1.40% of shares | medium |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | New | Common Stock | $3.28M | +127K | 126,540 0.38% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common Stock | $2.62M | +118K | 117,561 0.35% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | New | Common Stock | $1.23M | +48K | 47,580 0.14% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common Stock | $760.4K | +29K | 29,348 0.09% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Samsara BioCapital, L.P. | Passive13G | — |
| Sands Capital Life Sciences Pulse Fund III (DE), L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SGP | Common Stock | 85220G109 |